Alternance - Market Access (H/F)
Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. This press release and further information about Alexion can be found at: www.alexion.com.
RÉSUMÉ DU POSTE
Rattaché(e) à un membre de l’équipe Market Access France/BeLux, l’Alternant(e) Market Access participera au développement et déploiement de la stratégie d’accès au marché en France et BeLux.
Alternance à partir de septembre 2025
L’Alternant(e) rejoindra une filiale France/BeLux à taille humaine et aura l’opportunité d’être exposé à des projets variés et transverses.
PRINCIPALES RESPONSABILITES
- Analyses de prix, remboursement et benchmarking
- Participation au développement de dossiers d’accès au marché en France, BeLux
- Participation au développement de modèles économiques
- Evaluation de risques et opportunités
- Veille concurrentielle, environnementale et règlementaire des politiques de santé QUALIFICATIONS / PROFIL RECHERCHÉ
- Formation scientifique (Ingénieur, Pharmacien, Médecin), actuellement en Master Market Access / medico-économique
- Maitrise de l’anglais oral et écrit
- Capacité d’analyse et synthèse d’information
- Proactif(ve), rigoureux(se), curieux(se) et esprit d’équipe
Date Posted
18-mars-2025Closing Date
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation,age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy,(including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.